These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 11715727
1. [Antiviral agents in 2000--and then what next?]. Holý A. Cas Lek Cesk; 2001 Sep 27; 140(19):583-91. PubMed ID: 11715727 [Abstract] [Full Text] [Related]
3. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Lockhart SM, Salvaggio MR, Bronze MS, Greenfield RA. J Okla State Med Assoc; 2007 Oct 27; 100(10):388-95. PubMed ID: 18085096 [Abstract] [Full Text] [Related]
4. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Hofmann WP, Soriano V, Zeuzem S. Handb Exp Pharmacol; 2009 Oct 27; (189):321-46. PubMed ID: 19048206 [Abstract] [Full Text] [Related]
5. [Laboratory problems of chemotherapy of viral infections in humans]. Kańtoch M. Postepy Hig Med Dosw; 1992 Oct 27; 46(2):133-41. PubMed ID: 1470577 [Abstract] [Full Text] [Related]
6. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective. De Clercq E. Adv Virus Res; 2009 Oct 27; 73():1-53. PubMed ID: 19695380 [Abstract] [Full Text] [Related]
7. Acyclic nucleoside phosphonates: a key class of antiviral drugs. De Clercq E, Holý A. Nat Rev Drug Discov; 2005 Nov 27; 4(11):928-40. PubMed ID: 16264436 [Abstract] [Full Text] [Related]
8. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, Puoti M, Soriano V, Tural C, EACS Executive Committee. HIV Med; 2008 Feb 27; 9(2):82-8. PubMed ID: 18257771 [Abstract] [Full Text] [Related]
9. Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia. Jancel T, Penzak SR. Semin Hematol; 2009 Jul 27; 46(3):230-47. PubMed ID: 19549576 [Abstract] [Full Text] [Related]
10. Antiviral chemotherapy. Gore ME, Selby P. Br J Hosp Med; 1987 Jan 27; 37(1):22, 24-6. PubMed ID: 3028547 [Abstract] [Full Text] [Related]
12. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies]. Pár A, Takács M, Brojnás J, Berencsi G, Paál M, Horányi M, Miseta A, Hegedüs G, Mózsik G, Hunyady B. Orv Hetil; 2004 May 09; 145(19):987-92. PubMed ID: 15181733 [Abstract] [Full Text] [Related]
14. Treatment of HIV infections and AIDS: new horizons. Koech DK, Obel AO. East Afr Med J; 1990 Jul 09; 67(7 Suppl 2):SS77-81. PubMed ID: 2226236 [Abstract] [Full Text] [Related]
17. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV. Locarnini S, Warner N. Antivir Ther; 2007 Jul 09; 12 Suppl 3():H15-23. PubMed ID: 18284179 [Abstract] [Full Text] [Related]
18. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Expert Group, German Association for the Control of Virus Diseases and Paul-Ehrlich Society of Germany. J Clin Virol; 2004 Oct 09; 31(2):84-91. PubMed ID: 15364262 [Abstract] [Full Text] [Related]